{
  "id": 13194709,
  "title": "Olin Corp stock hits 52-week low at 14.94 USD",
  "url": "https://urgent.news/2026/10/09/olin-corp-stock-hits-52-week-low-at-14-94-usd",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-09T19:44:16.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/olin-corp-stock-hits-52week-low-at-1494-usd-93CH-4941630"
  },
  "original_language": "en",
  "account": "Olin Corp. experienced a significant drop in the value of its stock, reaching a 52-week low of $14.95 USD. This decline represents a 35% decrease in value over the past year and a 44% drop over the last six months. The chemical manufacturing company has been dealing with various challenges that have contributed to this downturn.\n\nInvestors are watching the situation closely as the stock navigates market pressures and industry-specific obstacles. According to InvestingPro data, the stock is currently undervalued relative to its Fair Value, and the company offers a 5.1% dividend yield. For additional insights, investors have access to Olin's Pro Research Report, which covers this company and 1,400+ other US equities.\n\nIn a separate development, Olin Corp. reported disappointing second-quarter 2026 financial results. The company posted an adjusted loss of $0.12 per share on revenue of $1.74 billion, which fell short of Wall Street's expectations. Factors contributing to these results included volatile chemical markets, an unplanned plant outage, and cash outflows related to litigation. Analyst firms have responded to these developments with mixed opinions. Wells Fargo downgraded Olin to an Equal Weight rating, citing a less favorable chlor-alkali market and stagnant pricing for key products. Truist Securities and RBC Capital lowered their price targets for Olin stock to $20, taking into account ongoing outage costs and a weaker third-quarter outlook. In contrast, KeyBanc initiated coverage with an Overweight rating, expressing optimism about a potential recovery in the chlor-alkali sector. These mixed assessments provide investors with a variety of perspectives on Olin's current position and future prospects.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Vir Biotechnology stock hits 52-week high at 11.96 USD",
        "url": "https://urgent.news/2026/10/09/vir-biotechnology-stock-hits-52-week-high-at-11-96-usd",
        "published": "2026-10-09T17:20:25.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}